1744 - "EULA for Ukraine"
No Agenda Show
00:00
Vaccine Misinformation and Obesity Drug Market Trends
This chapter explores the controversies surrounding vaccine misinformation and the evolving landscape of obesity drugs, particularly focusing on how companies like Eli Lilly and Novo Nordisk adjust their strategies. The discussion sheds light on the implications of pharmaceutical pricing practices and the intersection of insurance dynamics and consumer health.
Transcript
Play full episode
